Last updated: March 8, 2026
What does the scope and claims of patent CL2020002165 cover?
Patent CL2020002165 is a pharmaceutical patent granted in Chile. Its primary focus is on a novel composition, formulation, or method related to a specific drug or therapeutic application. The patent's claims define its scope, outlining the protected technology and its variants.
Patent Claims Overview
- Independent Claims: These specify the core invention—likely describing the chemical composition, formulation, or a method of manufacturing or treatment.
- Dependent Claims: These narrow the protection to particular embodiments, such as specific dosages, delivery systems, or treatment indications.
Based on standard patent practice in the pharmaceutical industry, CL2020002165 probably guards:
- A novel active ingredient or a novel combination of active ingredients.
- A specific formulation with improved stability, bioavailability, or efficacy.
- A method of treatment for a particular disease or condition.
Common Patent Claim Types in Pharma
| Category |
Typical Claims |
Application in Chile Patent CL2020002165 |
| Composition |
New chemical entities, combinations |
Likely covers the drug or related formulations |
| Method of Use |
Specific therapeutic methods |
May include treatment protocols |
| Formulation |
Dose forms, delivery systems |
Could specify novel dosage forms |
Claim Scope Analysis
- Broad Claims: Cover the main active compound or method, providing extensive protection.
- Narrow Claims: Focus on specific molecular structures, dosage, or delivery method, limiting scope but strengthening enforceability.
Assessment determines if claims are novel and non-obvious under Chilean patent law, which adheres to the standards set by the Patent Law No. 19,039.
What is the patent landscape surrounding CL2020002165?
The patent landscape includes prior art, similar patents in Chile, and international filings influencing patentability and enforceability.
Chilean and International Patents
- National filings: Chile's patent examiners consider prior art from Latin America, the US, and Europe.
- Regional and international priorities: The patent may claim priority from earlier filings in WIPO or other jurisdictions.
- Similar patents: Other patents for similar compounds, formulations, or methods may impact scope and potential patent conflicts.
Patent Filing Timeline and Status
- Filing date: Likely in 2020.
- Grant date: The patent is granted, indicating the examiner accepted the claims as novel and inventive.
- Term: Chilean patents last 20 years from filing, subject to renewal payments.
Patent Classification
The patent likely falls under the International Patent Classification (IPC):
- A61K (Preparations for medical, dental, or hygienic purposes)
- C07D (Heterocyclic compounds)
- Possibly combined with other classifications depending on the invention specifics.
Patent Litigation and Enforcement Environment
While Chile's intellectual property rights enforcement is developed, pharmaceutical patents are often subject to challenges. The landscape includes:
- Invalidity actions based on prior art.
- Patent linkage, delays, or oppositions, especially if aligned with international treaties.
- Market-specific factors: Chile's patent laws support compulsory licensing under certain conditions, which impacts exclusivity.
Comparative Analysis
| Aspect |
Chile Patent CL2020002165 |
Regional/Global Patents |
| Breadth of Claims |
Likely broad but specific to local claims |
Can be broader if filed internationally |
| Patent Term |
20 years from filing |
Same in most jurisdictions; can vary if patent term extensions apply |
| Enforcement |
Supported by Chilean law; subject to challenge |
Similar legal framework in Latin America; enforcement varies |
| Patentability Standards |
Novelty, inventive step, industrial applicability |
Similar standards; measured against comprehensive prior art searches |
Key Takeaways
- Patent CL2020002165 primarily covers a specific drug formulation or method with claims likely including compositions and uses.
- Its scope depends on claim breadth—broad claims protect larger variants but face higher scrutiny; narrow claims may be easier to defend but offer limited scope.
- The patent landscape includes prior art from Latin America, the US, and Europe, influencing its patentability.
- Enforcement actions are possible but require vigilance against invalidation or licensing challenges.
- Regional differences in patent law impact enforcement and market exclusivity.
FAQs
1. Does the patent cover the active pharmaceutical ingredient or only formulations?
The specific claims are needed for confirmation, but typically, patents cover both active ingredients and formulations if they are novel.
2. What are the most significant risks of patent infringement in Chile?
Challenging prior art, invalidity claims, and patent workarounds pose risks. Enforcement depends on legal processes and market conditions.
3. How does Chile’s patent law affect pharma patent strategies?
Chile emphasizes novelty, inventive step, and industrial applicability, requiring detailed prior art searches and possibly narrower claims to secure strong protection.
4. Can patent CL2020002165 be challenged post-grant?
Yes, through opposition or invalidity procedures within Chile’s legal framework or in international patent authorities if related filings exist.
5. What is the potential for extending patent rights in Chile?
Patent extensions are not commonly granted; exclusivity is primarily based on the original 20-year term.
References
- Chilean Patent Law No. 19,039. (1992). Retrieved from [Chile patent law official site].
